41P Phase I analysis of ubamatamab (MUC16xCD3 bispecific antibody) in patients with recurrent ovarian cancer K.N. Moore,D. O'Malley,E. Van Nieuwenhuysen, E. Hamilton,R.E. O'Cearbhaill,O. Yeku, S. Bouberhan, J.Y. Hou, M. Peterman,P. Goncalves,T. Schmidt,S-Y. Yoo, M. Zhu, I. Lowy, T. Rowlands,T. Uldrick, E.A. Miller, J. LiuESMO Open（2023）引用 0|浏览8暂无评分关键词muc16xcd3 bispecific antibody,recurrent ovarian cancer,ubamatamabAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
